Radboud Annals of Medical Students

RAMS

  • Home
  • News
    • Newsletter archive
  • About
    • RAMS
    • The Board
      • The General Board
        • The General Board (2021-2022)
        • Previous General Boards
      • The Editorial Board
        • The Editorial Board (2021-2022)
        • Previous Editorial Boards
    • The Supervisory Board
    • Reviewers and Editors
    • RAMS Committees
      • Symposium Committee
      • Masterclass Committee
  • Editions
    • 2021-2022
      • Twentieth Edition – September 2021
      • Twentyfirst Edition – December 2021
      • Twenty second Edition – March 2022
    • 2020-2021
      • Sixteenth edition – September 2020
      • Seventeenth edition – December 2020
      • Eighteenth edition – March 2021
      • Nineteenth Edition – June 2021
    • 2019-2020
      • Fourteenth edition – December 2019
      • Fifteenth edition – April 2020
      • Sixteenth edition – September 2020
    • 2018-2019
      • Eleventh Edition – September 2018
      • Twelfth Edition – January 2019
      • Thirteenth edition – May 2019
    • 2017 – 2018
      • Ninth Edition – November 2017
      • Tenth Edition – February 2018
    • 2016-2017
      • Sixth Edition – November 2016
      • Seventh Edition – March 2017
      • Eighth Edition – July 2017
    • 2015-2016
      • Third Edition – November 2015
      • Fourth Edition – March 2016
      • Fifth Edition – June 2016
    • 2014-2015
      • Pilot Edition – June 2014
      • First Edition – January 2015
      • Second Edition – June 2015
  • For Authors
    • Submit your Article
    • Research internship
  • For Supervisors
  • For Reviewers
  • Contact
  • Privacy policy
Je bent hier: Home / News / The power of plants: a cure for COVID-19?

The power of plants: a cure for COVID-19?

15 september 2021 by Rams

Minke Holwerda, BSc Biomedical Sciences

Unless you have been living under a rock, it has probably not escaped you that we are currently in the midst of a worldwide pandemic, caused by severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). While vaccines are being developed, produced, and injected in a (more or less) high tempo, a cure for coronavirus disease 2019 (COVID-19) has not yet been found. 

In the race for the COVID-19 cure, some countries have turned to exploring the potential of plant-based medicine [1]. Plant-based medicine is an ancient practice which plays a role in traditional medicine as well as modern drug development [2, 3]. Plants produce secondary metabolites which assist in the survival of the plant, such as alkaloids, flavonoids, phenolic acids, and terpenoids[2, 4]. These compounds have, among others, anti-inflammatory, antioxidant,  anticancerous, and – most importantly – antiviral properties [4]. Well-known examples of plant-based medicines are acetylsalicylic acid (aspirin), which is isolated from willow tree bark, and artemisinin, which is extracted from the plant Artemisia annua and used as treatment for malaria [2, 5]. 

A wide range of plants are currently being reviewed for their potential to treat COVID-19, including those that can be found in the average Dutch kitchen cabinet or garden. For example, research is being done into Anthemis hyaline, better known as chamomile. In one study, virus load decreased after adding extracts of Anthemis hyaline to CoV infected cells [6].

Curcuma Longa contains curcumin, which is a polyphenol that has previously been shown to have anti-viral activity against SARS coronavirus [7].  This name might sound familiar to you since curcuma, a spice currently very popular due to its superfood-status, is also made from this plant. A recent molecular docking study reported that curcumin binds and inhibits SARS-CoV-2 target receptors, supporting the use of this plant as prophylaxis against SARS-CoV-2 [8]. 

Another promising contender is a compound called ‘diammonium glycyrrhizinate’ found in Glycyrrhiza glabra, the plant from which liquorice is made. In traditional medicine, liquorice is used against colds, coughs, and to calm disturbed digestion, and diammonium glycyrrhizinate can be used to treat liver damage caused by hepatitis B due to its anti-inflammatory properties [9]. Recently, clinicals trials have been approved researching diammonium glycyrrhizinate in combination with vitamin C as therapy for COVID-19[10]. 

The use of plant-based medicine has many advantages. In countries with a rich tradition of herbal medicine, plant-based medicines have been used in a clinical setting for a long time, repeatedly proving their efficacy and safety. Theoretically, herbal medicines with known antiviral properties and established safety could immediately be used to treat COVID-19 patients [9]. This even more so because they are often widely available, in contrast to other medicines such as the recently approved remdesivir [11, 12].  In particular in low- and middle-income countries, where up to four billion people already depend on plant-based medicine as their primary source of healthcare, this is an attractive prospect [13] . 

However, a lot has to happen before any traditional medicine is turned into a modern drug. Because plants contain multiple phytochemicals, the exact mechanism of action is often unclear, and it takes a long time to develop high-quality plant-based medicine with sufficient data on long-term safety and pharmacokinetics. In addition, developing reference standards is also more challenging for plant-based medicine than for synthetic drugs [1]. 

So, unfortunately, plant-based medicine is no quick fix for our COVID-19 cure conundrum. You might enjoy a calming cup of chamomile tea, curcuma in your food, and some liquorice to snack on, but this is no replacement for the vaccine or test needed to hit the clubs again!’

1. Lim, X.Y., et al. Medicinal Plants in COVID-19: Potential and Limitations. Front Pharmacol 12, 611408 (2021).

2. Dias, D.A., et al. A historical overview of natural products in drug discovery. Metabolites 2, 303-336 (2012).

3. Yuan, H., et al. The Traditional Medicine and Modern Medicine from Natural Products. Molecules 21(2016).

4. Sohail, M.I., et al. Phytomedicine and the COVID-19 pandemic, (Phytomedicine. 2021:693-708. doi: 10.1016/B978-0-12-824109-7.00005-4. Epub 2021 Feb 26.).

5. Tu, Y. The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nat Med 17, 1217-1220 (2011).

6. Ulasli, M., et al. The effects of Nigella sativa (Ns), Anthemis hyalina (Ah) and Citrus sinensis (Cs) extracts on the replication of coronavirus and the expression of TRP genes family. Mol Biol Rep 41, 1703-1711 (2014).

7. Singh, N.A., et al. Spices and herbs: Potential antiviral preventives and immunity boosters during COVID-19. Phytother Res (2021).

8. Utomo, R.Y., et al. Revealing the Potency of Citrus and Galangal Constituents to Halt SARS-CoV-2 Infection. Preprints (2020).

9. Anonymous. Redeploying plant defences. Nat Plants 6, 177 (2020).

10. Lin, J. A randomized, open, controlled trial for diammonium glycyrrhizinate enteric-coated capsules combined with vitamin C tablets in the treatment of common novel coronavirus pneumonia (COVID-19) in the basic of clinical standard antiviral treatment to evaluate the safety and efficiency. in, Vol.  (ed.^(eds. (Zhongnan Hospital of Wuhan University, 2020).

11. Huang, J., et al. Current Prevention of COVID-19: Natural Products and Herbal Medicine. Front Pharmacol 11, 588508 (2020).

12. Adhikari, S., et al. Remdesivir in COVID-19 management: availability and relevance to low- and middle-income countries. Drugs Ther Perspect, 1-3 (2020).

13. Ekor, M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol 4, 177 (2014).

Categorie: News, Uncategorized

RAMS Newsletter

RAMS complies to the GDPR. By submitting your e-mail address to us you agree with our Privacy Policy.

Social Media


Sponsors & Partners

  • Brian Gardner
  • Lauren Mancke
  • Nathan Rice
  • Nick Croft
  • Rafal Tomal
  • Ron Rennick
© Copyright 2014 RADBOUD ANNALS OF MEDICAL STUDENTS · All Rights Reserved · Powered by PLatform11
Beheer cookie toestemming

Om de beste ervaringen te bieden, gebruiken wij technologieën zoals cookies om informatie over je apparaat op te slaan en/of te raadplegen. Door in te stemmen met deze technologieën kunnen wij gegevens zoals surfgedrag of unieke ID's op deze site verwerken. Als je geen toestemming geeft of uw toestemming intrekt, kan dit een nadelige invloed hebben op bepaalde functies en mogelijkheden.

Functioneel Altijd actief
De technische opslag of toegang is strikt noodzakelijk voor het legitieme doel het gebruik mogelijk te maken van een specifieke dienst waarom de abonnee of gebruiker uitdrukkelijk heeft gevraagd, of met als enig doel de uitvoering van de transmissie van een communicatie over een elektronisch communicatienetwerk.
Voorkeuren
De technische opslag of toegang is noodzakelijk voor het legitieme doel voorkeuren op te slaan die niet door de abonnee of gebruiker zijn aangevraagd.
Statistieken
De technische opslag of toegang die uitsluitend voor statistische doeleinden wordt gebruikt. De technische opslag of toegang die uitsluitend wordt gebruikt voor anonieme statistische doeleinden. Zonder dagvaarding, vrijwillige naleving door uw Internet Service Provider, of aanvullende gegevens van een derde partij, kan informatie die alleen voor dit doel wordt opgeslagen of opgehaald gewoonlijk niet worden gebruikt om je te identificeren.
Marketing
De technische opslag of toegang is nodig om gebruikersprofielen op te stellen voor het verzenden van reclame, of om de gebruiker op een website of over verschillende websites te volgen voor soortgelijke marketingdoeleinden.
Beheer opties Beheer diensten Beheer leveranciers Lees meer over deze doeleinden
Bekijk voorkeuren
{title} {title} {title}